Chemokines are a group of small secreted proteins (8–10 kDa) produced and released by a wide variety of cell types. They were originally described as mediators of leukocyte recruitment, which is essential in acute and chronic inflammation. They also play a critical role in many pathophysiological processes such as allergic responses, infections and autoimmune diseases, tumor growth and hematopoietic development. This review introduces the three supergene families of chemokines (CXC, CC and C) with emphasis on their important role in different states in humans and in animal models with parasitic diseases. The concentration of transcription and translation of the cytokines and chemokines in the parasitic diseases may be an important marker for evaluation of the inflammatory state.
ContiP., PangX., BoucherW.. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase.Blood1997; 89: 4120–7.
2.
TheoharidesT.C., ContiP.. Mast cells: the Jekyll and Hyde of tumor growth.Trends Immunol2004; 25: 235–41.
3.
ContiP., RealeM., BarbacaneR.C., LetourneauR., TheoharidesT.C.. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice.FASEB J1998; 12: 1693–700.
FranchiC., CainelliG., FrigerioE., GaruttiC., AltomareG.F.. Association of cyclosporine and 311 nM UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach.Int J Immunopathol Pharmacol2004; 17: 401–6.
6.
BalleriniP., Di IorioP., CiccarelliR.. P2Y1 and cysteinyl-leukotriene receptors mediate purine and cysteinyl-leukotriene co-release in primary cultures of rat microglia.Int J Immunopathol Pharmacol2005; 18: 255–68.
7.
ProsperiC., ScaliC., BarbaM., BellucciA., GiovanniniM.G., PepeuG., CasamentiF.. Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abe-ta(1–42)-induced brain inflammation and neuronal damage in the rat.Int J Innunopathol Pharmacol2004; 17: 317–30.
8.
TrubianiO., Di PrimioR., TrainiT.. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament.Int J Immunopathol Pharmacol2005; 18: 213–22.
9.
BaggioliniM., DewaldB., MoserB.. Interleukin-8 and related chemotactic cytokines – CXC and CC chemokines.Adv Immunol1994; 55: 97–179.
10.
KempurajD., FrydasS., KaragouniE.. Cytokines and the brain.Int J Immunopathol Pharmacol2004; 17: 229–32.
CavalieriS., RotoliM., FelicianiC., AmerioP.. Expression of the high-affinity laminin receptor (67 kDa) in normal human skin and appendages.Int J Immunopathol Pharmacol2005; 18: 223–32.
14.
PetrarcaC., FrydasS., DonelanJ.. Interleukin 27 (IL-27): a novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation.Int J Immunopathol Pharmacol2005; 18: 191–4.
15.
FrydasS., KaragouniE., HatzistilianouM.. Cytokines and allergic disorders: a revised study.Int J Immunopathol Pharmacol2004; 17: 233–6.
16.
SallustoF., MackayC.R., LanzavecchiaA.. The role of chemokine receptors in primary, effector, and memory immune responses.Annu Rev Immunol2000; 21: 593–620.
17.
Von AndrianU.H., MackayC.. T-cell function and migration. Two sides of the same coin.New Engl J Med2000; 343: 1020–34.
18.
ContiP., PangX., BoucherW.. RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites.J Pathol1997; 183: 352–8.
19.
TsagozisP., KaragouniE., DotsikaE.. Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis.Int J Immunopathol Pharmacol2004; 17: 343–52.
20.
LukacsN.N., StrieterR.M., WarmingtonK., LincolnP., ChensueS.W., KunkelS.L.. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation.J Immunol1997; 158: 4398–404.
KempurajD., DonelanJ., FrydasS., IezziT., ContiF., BoucherW., PapadopoulouN.G., MadhappanB., LetourneauL., CaoJ., Sabati-noG., MeneghiniF., StellinL., VernaN., RiccioniG., TheoharidesT.C.. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities.Int J immunopathol Pharmacol2004; 17: 103–6.
24.
PannelliniT., IezziM., Di CarloE., EleuterioE., ColettiA., ModestiA., RosiniS., NeriM., MusianiP.. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis.Int J Immunopathol Pharmacol2004; 17: 171–80.
25.
AvgerinosD.V., TheoharidesT.C.. Mesenteric traction syndrome or gut in distress.Int J Immunopathol Pharmacol2005; 18: 195–200.
YanX.T., TumpeyT.M., KunkelS.L., OakesJ.E., LauschR.N.. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea.Invest Ophthalmol Vis Sci1998; 39: 1854–62.
28.
Ben-BaruchA., MichielD.F., OppenheimJ.J.. Signals and receptors involved in recruitment of inflammatory cells.J Biol Chem1995; 270: 11703–6.
29.
MartiniF., AgratiC., D'OffiziG., PocciaF.. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells.Int J Immunopathol Pharmacol2005; 18: 269–76.
30.
AlexandrakisM.G., PassamF.H., PappaC.A.. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.Int J Immunopathol Pharmacol2005; 18: 287–96.
31.
CenturioneL., Di GiulioC., SantavenereE.. Protein kinase C zeta regulation of hypertrophic and apoptotic events occurring during rat neonatal heart development and growth.Int J Immunopathol Pharmacol2005; 18: 49–58.
32.
van ZandbergenG., HermannN., LaufsH., SolbachW., LaskayT.. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes.Infect Immun2002; 70: 4177–84.
33.
BrandonisioO., PanaroM.A., FumarolaI.. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages.Clin Exp Med2002; 2: 125–9.
34.
KempurajD., DeviR.S., MadhappanB., ContiP., NazerM.Y., ChristodoulouS., ReginaldJ., SuthinthirarajanN., NamasivayamA.. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors.Int J Immunopathol Pharmacol2004; 17: 57–64.
35.
CognasseF., ChavarinP., AcquariS.. Differential downstream effects of ligation mediated by membrane or soluble CD40L and agnostic Ab: a study on purified human B cells.Int J Immunopathol Pharmacol2005; 18: 65–74.
36.
JiJ., SunJ., SoongL.. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensi.Infect Immun2003; 71: 4278–88.
37.
MarchisioM., GrimleyP.M., Di BaldassarreA., SantavenereE., MisciaS.. Novel shift of Jak/Stat signalling characterizes the protective effect of aurintricarboxylic acid (ATA) from tumor necrosis factor-alpha toxicity in human B lymphocytes.Int J Immunopathol Pharmacol2004; 17: 5–14.
38.
RitterU., MollH., LaskayT.. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis.J Infect Dis1996; 173: 699–709.
39.
RitterU., MollH.. Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-γ and is antagonized by IL-4.Eur J Immunol2000; 30: 3111–20.
40.
MatteC., OlivierM.. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.J Infect Dis2002; 185: 673–81.
41.
OhmoriY., WynerL., NarumiS., ArmstrongD., StolerM., HamiltonT.A.. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo.Am J Pathol1993; 142: 861–70.
42.
AlibertiJ.C., MachadoF.S., SoutoJ.T.. Beta-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi.Infect Immun1999; 67: 4819–26.
43.
LimaM.F., ZhangY., VillaltaF.. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages.Cell Mol Biol1997; 43: 1067–76.
44.
SharafeldinA., EltayebR., PashenkovM., BakhietM.. Chemokines are produced in the brain early during the course of experimental African trypanosomiasis.J Neuroimmunol2000; 103: 165–70.
45.
BlissS.K., MarshallA.J., ZhangY., DenkersE.Y.. Human polymorphonuclear leukocytes produce IL-12, TNF-αlpha and the chemokines macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii antigen.J Immunol1999; 162: 7369.
46.
KimJ.M., OhY.K., KimY.J., ChoS.J., AhnM.H., ChoY.J.. Nuclear factor kappa B plays a major role in the regulation of HeLa cells in response to Toxoplasma gondii infection.Parasitol Res2001; 87: 758–63.
47.
RossiR.E., MonasteroloG.. A pilot study of feasibility of ultra rush (20–25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.Int J Immunopathol Pharmacol2005; 18: 277–86.
48.
MussoT., CappelloP., StornelloS.. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes.Int J Immunopathol Pharmacol2005; 18: 339–50.
49.
TheodoridesY., FrydasS., RallisT.. MCP-1 and MIP-2 levels during Echinococcus granulosus infections in mice.J Helminth2001; 75: 205–8.
50.
RealeM., FrydasS., BarbacaneR.C.. Induction of monocyte chemotactic protein (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.Mol Cell Biochem1998; 179: 1–8.
51.
TrubianiO., GuarnieriS., OrcianiM., SalvoliniE., Di PrimioR.. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis.Int J Immunopathol Pharmacol2004; 17: 293–300.
52.
Appert-CollinA., DuongF.H.T., Passilly DegraceP., WarterJ-M, PoindronP., GiesJ-P. MAPK activation via 5-hydroxy-tryptamine 1A receptor is involved in the neuroprotective effects of xaliproden.Int J Immunopathol Pharmacol2005; 18: 21–32.
53.
Di GiannantonioM., FrydasS., KempurajD.. Cytokines in stress.Int J Immunopathol Pharmacol2005; 18: 1–6.
TheoharidesT.C., SantG.R.. A pilot open label study of Cystoprotek® in interstitial cystitis.Int J Immunopathol Pharmacol2005; 18: 183–8.
56.
FrydasS., PapaioannouN., PapazahariadouM.. Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound l-mimosine.Int J Immunopathol Pharmacol2005; 18: 85–94.
GuidiL., CostanzoM., CiarnielloM.. Increased levels of NF-kB inhibitors (IκBα and IκBγ) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.Int J Immunopathol Pharmacol2005; 18: 155–64.
59.
TotaroR., PassacantandoA., RussoT.. Effects of interferon beta, cyclophosphamide, and azathioprine on cytokine profile in patients with multiple sclerosis.Int J Immunopathol Pharmacol2005; 18: 377–384.
60.
SommaP., Lo MuzioL., MansuetoG.. Squamous cell carcinoma of the lower lip: Fas/FasL expression, lymphocyte subtypes and outcome.Int J Immunopathol Pharmacol2005; 18: 59–64.
61.
CognasseF., ChavarinP., AcquariS.. Differential downstream effects of ligation mediated by membrane or soluble CD40L and agnostic Ab: a study on purified human B cells.Int J Immunopathol Pharmacol2005; 18: 65–74.
62.
FalkensammerB., FasserW., SchererK.. Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the human immunodeficiency virus type 1.Int J Immunopathol Pharmacol2005; 18: 145–54.
63.
YamakiK., UchidaH., LiX.. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice.Int J Immunopathol Pharmacol2005; 18: 133–44.
64.
ShrivastavaP., SinghS.M., SinghN.. Activation of tumor-associated macrophages by thymosin alpha 1.Int J Immunopathol Pharmacol2004; 17: 39–47.
65.
ContiP., RealeM., NicolaiM.. Bacillus Calmette-Guérin potentiates monocyte responses to lipopolysaccharide-induced tumor necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patients.Cancer Immunol Immunother1994; 38: 365–71.
66.
Sodin-SemrlS., SpagnoloA., MikusR., BarbaroB., VargaJ., FioreS.. Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor.Int J Immunopathol Pharmacol2004; 17: 145–56.
67.
Appert-CollinA., DuongF.H., Passilly-DegraceP., GiesJ.P., WarterJ.M., PoindronP.. Quantification of neurotrophin mRNA expression in PMN mouse: modulation by xaliproden.Int J Immunopathol Pharmacol2004; 17: 157–64.
68.
CrossM.L.. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites.Int J Immunopathol Pharmacol2004; 17: 127–34.
